Research and Markets (http://www.researchandmarkets.com/research/f9cdnc/us_companion)
has announced the addition of the "US
Companion Diagnostics Market Trends and Insights" report to
A complete companion diagnostic market analysis must include both
developers of targeted drugs and developers of companion diagnostic
tests. This research deliverable discusses important trends in the U.S.
companion diagnostics market including emerging opportunities with novel
drug classes and new clinical markers like circulating tumor cells.
Emerging therapeutic areas beyond oncology for companion diagnostics are
also discussed along with key competitors, rx-cdx partnerships,
regulatory overview, and therapeutic pipelines with companion biomarkers.
For more information visit http://www.researchandmarkets.com/research/f9cdnc/us_companion
[ Back To NFVZone's Homepage ]